Clinical Trial Update: The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy [Phase 2]

View source ↗

Summary

Phase 2 study of Avelumab with radical radiotherapy in unresectable cutaneous squamous cell carcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• BAVENCIO (AVELUMAB)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Squamous Cell Carcinoma of the Skin | Phase 2 | Status: TERMINATED